SANDOZ MYCOPHENOLIC ACID DIN 02465809
Status: Cancelled Pre Market
Holder: SANDOZ CANADA INCORPORATED
Molecule: MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM)
Health Canada record
| Active ingredient(s) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG |
|---|---|
| Dosage form | Tablet (Enteric-Coated) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L04AA06 MYCOPHENOLIC ACID |
| Original market date | |
| Current status date | 01-Aug-2019 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sandoz Canada Incorporated — licence 101370, currently licensed, last inspection rating C (2025-02-25).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02372738 | APO-MYCOPHENOLIC ACID | APOTEX INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02372746 | APO-MYCOPHENOLIC ACID | APOTEX INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02518511 | JAMP MYCOPHENOLIC ACID | JAMP PHARMA CORPORATION | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02518538 | JAMP MYCOPHENOLIC ACID | JAMP PHARMA CORPORATION | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02511681 | MAR-MYCOPHENOLIC ACID | MARCAN PHARMACEUTICALS INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02511673 | MAR-MYCOPHENOLIC ACID | MARCAN PHARMACEUTICALS INC | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02264560 | MYFORTIC | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Delayed-Release) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 180 MG | Marketed |
| 02264579 | MYFORTIC | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet (Delayed-Release) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Marketed |
| 02465817 | SANDOZ MYCOPHENOLIC ACID | SANDOZ CANADA INCORPORATED | Tablet (Enteric-Coated) | MYCOPHENOLIC ACID (MYCOPHENOLATE SODIUM) 360 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19497 | 2017-07-06 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |